Recent Advances in the Synthesis of 1,2,4-Triazole-Based Compounds with Antimicrobial Activity

Abstract

The rapid emergence of antimicrobial resistance has created an urgent need for the development of new and effective therapeutic agents. Among various heterocyclic scaffolds, 1,2,4-triazole has gained significant attention due to its remarkable pharmacological properties, including broad-spectrum antimicrobial activity. This review highlights recent advances in the synthesis of 1,2,4-triazole-based compounds, focusing on both conventional and modern synthetic methodologies. Strategies such as cyclization of acid hydrazides, thiosemicarbazide routes, and one-pot reactions are discussed alongside emerging approaches including microwave-assisted, ultrasound-assisted, and green synthesis techniques. Furthermore, the impact of structural modifications on antimicrobial activity is analyzed, emphasizing structure–activity relationship (SAR) studies involving electron-withdrawing and electron-donating substituents. The review also summarizes reported antibacterial and antifungal activities of various derivatives against clinically relevant pathogens. In addition, recent in-silico studies, including molecular docking and ADME predictions, are discussed to provide insights into the mechanism of action and drug-likeness of these compounds. Overall, 1,2,4-triazole derivatives continue to represent a promising class of molecules in the search for novel antimicrobial agents, and further research in this area may contribute significantly to overcoming current challenges in infectious disease treatment.

Keywords

Anti-Microbial, Structure Activity Relationship (SAR),1,2,4-trizole derivatives, Treatment, Novel Anti-Microbial agents

Introduction

The increasing prevalence of antimicrobial resistance (AMR) has become a serious global health concern, significantly reducing the effectiveness of existing therapeutic agents and leading to higher morbidity and mortality rates. Pathogenic microorganisms such as Staphylococcus aureus, Escherichia coli, and Candida albicans have developed resistance to multiple drugs, thereby necessitating the discovery and development of new antimicrobial agents with novel mechanisms of action [1], [2]. The continuous emergence of multidrug-resistant strains has prompted researchers to explore heterocyclic scaffolds that can serve as potential leads in antimicrobial drug discovery.

Heterocyclic compounds play a crucial role in medicinal chemistry due to their structural diversity and wide range of biological activities. Among them, the 1,2,4-triazole ring system has attracted considerable attention owing to its unique chemical and pharmacological properties. The presence of three nitrogen atoms in the five-membered ring enhances its ability to form hydrogen bonds and coordinate with biological targets, making it an important pharmacophore in drug design [3]. Several clinically used drugs, such as Fluconazole and Itraconazole, contain the triazole moiety and exhibit potent antifungal activity, highlighting the therapeutic relevance of this scaffold.

The synthesis of 1,2,4-triazole derivatives has evolved significantly over the years, with numerous conventional and modern methodologies being developed. Traditional synthetic routes typically involve cyclization reactions of acid hydrazides, thiosemicarbazides, or related intermediates [4]. However, these methods often suffer from limitations such as long reaction times, low yields, and harsh reaction conditions. In recent years, advancements in synthetic chemistry have led to the development of more efficient and environmentally friendly approaches, including microwave-assisted synthesis, ultrasound-promoted reactions, and solvent-free conditions, which offer improved yields and reduced reaction times [5], [6].

Structural modification of the triazole nucleus has been widely explored to enhance antimicrobial activity. Substitution at different positions of the triazole ring with electron-withdrawing or electron-donating groups significantly influences biological activity and selectivity. In particular, derivatives containing halogens, nitro groups, or heterocyclic moieties have demonstrated enhanced antibacterial and antifungal properties [7]. Additionally, the incorporation of thiol and Schiff base functionalities into the triazole framework has been reported to improve binding interactions with microbial enzymes, thereby increasing potency.

In parallel with synthetic advancements, computational approaches such as molecular docking and pharmacokinetic prediction have become essential tools in modern drug discovery. In-silico techniques enable the prediction of binding interactions between triazole derivatives and key microbial targets, such as DNA gyrase and dihydrofolate reductase, thereby providing insights into their mechanism of action and guiding rational drug design [8]. These methods also facilitate the evaluation of drug-likeness and ADME properties, reducing the likelihood of late-stage drug failure.

In this context, the present review aims to provide a comprehensive overview of recent advances in the synthesis of 1,2,4-triazole-based compounds with antimicrobial activity. Emphasis is placed on synthetic strategies, structure–activity relationships, biological evaluation, and in-silico studies, highlighting the potential of these compounds as promising candidates for the development of new antimicrobial agents.

2. Chemistry of 1,2,4-Triazole

2.1 Structure and Numbering

1,2,4-Triazole is a five-membered aromatic heterocyclic compound containing three nitrogen atoms and two carbon atoms within the ring. The nitrogen atoms are positioned at the 1st, 2nd, and 4th positions, giving rise to the name 1,2,4-triazole. The ring exhibits aromatic character due to the delocalization of six π-electrons, which satisfies Hückel’s rule and contributes to its remarkable stability. The standard numbering begins with the nitrogen atom adjacent to the carbon atom, proceeding in a manner that assigns the lowest possible numbers to the heteroatoms [1].

2.2 Physicochemical Properties

1,2,4-Triazole derivatives exhibit important physicochemical properties that make them attractive in medicinal chemistry. The presence of multiple nitrogen atoms imparts significant polarity and enhances hydrogen bonding capability, enabling strong interactions with biological targets such as enzymes and receptors. These compounds generally possess moderate solubility in polar solvents and display good thermal and chemical stability. Furthermore, the triazole ring can act as both a hydrogen bond donor and acceptor, which is essential for ligand–protein interactions [2].

The electron-rich nature of the ring also allows it to participate in coordination with metal ions and biological macromolecules. Additionally, substitution on the triazole ring significantly influences lipophilicity, electronic distribution, and pharmacokinetic behavior, which are critical parameters in drug design [3].

2.3 Tautomerism

1,2,4-Triazole exhibits tautomerism due to the presence of labile hydrogen atoms on nitrogen atoms. The most common tautomeric forms are the 1H-1,2,4-triazole and 4H-1,2,4-triazole forms, which interconvert through proton transfer. Among these, the 1H-tautomer is generally more stable in solution and solid state due to favorable electronic distribution and hydrogen bonding interactions [4].

Tautomerism plays a crucial role in determining the biological activity of triazole derivatives, as different tautomeric forms may interact differently with target proteins. This dynamic equilibrium can influence binding affinity, selectivity, and overall pharmacological activity.

2.4 Reactivity of 1,2,4-Triazole

The reactivity of 1,2,4-triazole is largely governed by its electron-rich nitrogen atoms and aromatic character. It undergoes various chemical transformations, including:

• N-alkylation and N-acylation reactions
• Electrophilic substitution at carbon atoms
• Nucleophilic substitution reactions
• Cyclization reactions leading to fused heterocycles

The presence of multiple nucleophilic sites allows selective functionalization, making it a versatile intermediate in organic synthesis. Moreover, the incorporation of functional groups such as thiol (–SH), amino (–NH?), and Schiff bases enhances its reactivity and biological activity [5].

2.5 Importance in Medicinal Chemistry

The 1,2,4-triazole nucleus is widely recognized as a privileged scaffold in drug discovery due to its ability to mimic amide and ester functionalities. Its derivatives exhibit a wide spectrum of biological activities, including antimicrobial, antifungal, antiviral, anti-inflammatory, and anticancer properties. The success of clinically used drugs such as Fluconazole and Itraconazole highlights the pharmacological importance of this heterocyclic system [6].

3. Synthetic Approaches to 1,2,4-Triazole Derivatives

The synthesis of 1,2,4-triazole derivatives has attracted considerable attention due to their wide-ranging biological activities, particularly antimicrobial properties. Various synthetic methodologies have been developed, including conventional cyclization routes, modern synthetic techniques, and green chemistry approaches. These methods enable structural diversity and improved efficiency in the preparation of triazole-based compounds.

3.1 Conventional Synthetic Methods

3.1.1 Cyclization of Acid Hydrazides

One of the most common approaches involves the cyclization of acid hydrazides. In this method, carboxylic acids or esters are first converted into hydrazides, which react with carbon disulfide under basic conditions to form dithiocarbazate intermediates. Subsequent cyclization leads to the formation of 1,2,4-triazole-3-thiol derivatives. This method is widely used due to its simplicity and availability of starting materials.

3.1.2 Synthesis via Thiosemicarbazides

Thiosemicarbazides are important intermediates in triazole synthesis. They are typically prepared by reacting hydrazides with isothiocyanates or carbon disulfide. Upon heating or treatment with base, intramolecular cyclization occurs to form the triazole ring. This route is particularly valuable for synthesizing thiol-substituted triazoles with enhanced biological activity.

3.1.3 Cyclization of Amidines and Hydrazones

Another classical route involves the cyclization of amidines, hydrazones, or nitrile derivatives with hydrazine-based reagents. These reactions proceed through nucleophilic addition followed by ring closure, allowing the introduction of diverse substituents and functional groups into the triazole framework.

3.2 Modern Synthetic Methodologies

3.2.1 Microwave-Assisted Synthesis

Microwave-assisted synthesis has emerged as a powerful technique for the rapid synthesis of 1,2,4-triazole derivatives. Compared to conventional heating, microwave irradiation significantly reduces reaction time, improves yield, and enhances selectivity. It also aligns with green chemistry principles by minimizing energy consumption and solvent use.

3.2.2 Multicomponent and One-Pot Reactions

Multicomponent reactions (MCRs) and one-pot synthesis strategies enable the formation of complex triazole derivatives in a single step. These methods improve atom economy and reduce purification steps. Recent studies have demonstrated the synthesis of functionalized triazoles using [3+2] annulation and other one-pot protocols, offering efficient and scalable approaches.

3.2.3 Metal-Free and Catalytic Approaches

Recent advances include metal-free and catalytic synthesis of triazoles, which avoid the use of toxic reagents and improve environmental sustainability. These methods often involve mild reaction conditions and provide high selectivity, making them suitable for pharmaceutical applications.

3.3 Green Synthesis Approaches

3.3.1 Microwave and Ultrasound-Assisted Green Synthesis

Green chemistry approaches emphasize environmentally benign conditions. Microwave and ultrasound-assisted methods reduce reaction time and solvent usage while increasing yield and efficiency. These techniques are increasingly preferred in modern synthetic laboratories.

3.3.2 Solvent-Free and Ionic Liquid-Based Synthesis

Solvent-free synthesis and the use of ionic liquids as green solvents have gained popularity due to their low toxicity and recyclability. These methods provide cleaner reactions, reduced waste generation, and improved sustainability in triazole synthesis.

4. Structural Modifications and SAR (Structure–Activity Relationship)

Structure–activity relationship (SAR) studies play a crucial role in understanding how structural variations in 1,2,4-triazole derivatives influence their antimicrobial activity. The biological efficacy of these compounds is highly dependent on the nature, position, and type of substituents attached to the triazole nucleus. Extensive research has demonstrated that rational modification of the triazole scaffold significantly enhances antimicrobial potency and selectivity.

4.1 Effect of Electron-Withdrawing Substituents

The introduction of electron-withdrawing groups (EWGs) such as nitro (–NO?), halogens (–Cl, –F), and cyano (–CN) at aromatic positions significantly enhances antimicrobial activity. These groups increase lipophilicity and facilitate better penetration through microbial cell membranes. Additionally, EWGs improve binding interactions with target enzymes such as DNA gyrase and dihydrofolate reductase (DHFR), leading to enhanced inhibitory activity.

Studies have shown that halogen-substituted triazole derivatives exhibit strong antibacterial activity against both Gram-positive and Gram-negative bacteria, including drug-resistant strains.

4.2 Effect of Electron-Donating Substituents

Electron-donating groups (EDGs) such as methyl (–CH?) and methoxy (–OCH?) influence the electronic density of the triazole ring and modulate biological activity. These substituents generally enhance lipophilicity and improve membrane permeability; however, excessive electron donation may reduce binding affinity with biological targets.

Moderate substitution with EDGs has been reported to improve antimicrobial activity, particularly when combined with other pharmacophores, suggesting a synergistic effect.

4.3 Role of Heterocyclic Substitution and Hybrid Molecules

The incorporation of additional heterocyclic moieties such as thiadiazole, quinoline, pyridine, and benzothiazole into the triazole framework significantly enhances antimicrobial activity. These hybrid molecules exhibit improved binding interactions due to increased molecular complexity and multiple interaction sites.

For example, triazole–thiadiazole hybrids have demonstrated superior antimicrobial activity compared to simple triazole derivatives, indicating the importance of pharmacophore hybridization. Similarly, fused and hybrid triazole systems show enhanced potency against resistant microbial strains.

4.4 Importance of Thiol (–SH) and Schiff Base Derivatives

The presence of thiol (–SH) groups in 1,2,4-triazole derivatives plays a significant role in enhancing antimicrobial activity. Thiol-containing compounds can form strong interactions with microbial enzymes and proteins, thereby improving inhibitory activity.

Schiff base derivatives of triazoles, formed by condensation with aldehydes or ketones, also exhibit enhanced antimicrobial properties. These derivatives provide additional binding sites and improve overall pharmacological activity through hydrogen bonding and coordination interactions.

4.5 Influence of Substitution Position on the Triazole Ring

The position of substitution on the triazole ring is critical in determining biological activity. Substituents at the 3- and 5-positions of the triazole ring have been reported to significantly influence antimicrobial potency. Proper positioning enhances interaction with active sites of microbial enzymes and improves selectivity.

SAR studies indicate that substitution patterns that optimize steric and electronic properties lead to improved activity and reduced toxicity.

4.6 Mechanistic Insights from SAR Studies

SAR analysis has revealed that 1,2,4-triazole derivatives exert antimicrobial activity through inhibition of key microbial enzymes such as:

• DNA gyrase
• Dihydrofolate reductase (DHFR)
• Glucosamine-6-phosphate synthase

The presence of appropriate substituents enhances binding affinity and stabilizes ligand–protein interactions, leading to improved antimicrobial efficacy.

5. Antimicrobial Activity of 1,2,4-Triazole Derivatives

1,2,4-Triazole derivatives have emerged as a significant class of heterocyclic compounds exhibiting broad-spectrum antimicrobial activity. Their effectiveness against a wide range of pathogenic microorganisms, including Gram-positive bacteria, Gram-negative bacteria, and fungi, has been extensively reported. The presence of nitrogen-rich heterocyclic systems enables strong interactions with biological targets, making these compounds promising candidates for antimicrobial drug development.

5.1 Antibacterial Activity

Numerous studies have demonstrated that 1,2,4-triazole derivatives possess potent antibacterial activity against both Gram-positive and Gram-negative bacteria such as Staphylococcus aureus, Bacillus subtilis, Escherichia coli, and Pseudomonas aeruginosa. These compounds often exhibit comparable or superior activity to standard antibiotics.

For instance, substituted 1,2,4-triazoles have shown minimum inhibitory concentration (MIC) values as low as 5 µg/mL, indicating strong antibacterial potency. The activity is largely influenced by substituents such as halogens, nitro groups, and heterocyclic moieties, which enhance membrane permeability and enzyme binding .Additionally, recent studies have reported that certain triazole derivatives exhibit excellent activity against multidrug-resistant (MDR) strains, including methicillin-resistant Staphylococcus aureus (MRSA), highlighting their therapeutic potential .

5.2 Antifungal Activity

1,2,4-Triazole derivatives are well-known for their antifungal activity, particularly due to their ability to inhibit fungal cytochrome P450 enzymes such as lanosterol 14α-demethylase. This leads to disruption of ergosterol biosynthesis, an essential component of fungal cell membranes.

Several synthesized derivatives have shown strong antifungal activity against Candida albicans, Aspergillus niger, and other pathogenic fungi. Some compounds exhibit activity comparable to or better than standard antifungal agents such as ketoconazole .

Moreover, newly developed triazole-thioether derivatives have demonstrated significant antifungal potency with low EC?? values, indicating high efficacy .

5.3 Broad-Spectrum Antimicrobial Activity

Many 1,2,4-triazole derivatives exhibit broad-spectrum activity, acting against both bacterial and fungal strains. For example, sulfonamide–triazole hybrids have shown high activity against Gram-positive bacteria, moderate activity against Gram-negative bacteria, and strong antifungal effects against Candida albicans .

The minimum inhibitory concentration (MIC) values for such compounds typically range between 3.12–25 µg/mL, indicating good antimicrobial efficacy .

5.4 Mechanism of Antimicrobial Action

The antimicrobial activity of 1,2,4-triazole derivatives is attributed to multiple mechanisms:

• Inhibition of DNA gyrase and DHFR → disrupts bacterial DNA replication
• Inhibition of ergosterol biosynthesis → antifungal action
• Interaction with microbial enzymes → enzyme inactivation
• Disruption of cell membrane integrity

Studies suggest that triazole derivatives can bind effectively to key microbial enzymes such as DNA gyrase, glucosamine-6-phosphate synthase, and dihydrofolate reductase, thereby inhibiting essential metabolic pathways .

5.5 Structure–Activity Correlation in Antimicrobial Activity

The antimicrobial efficacy of 1,2,4-triazole derivatives is strongly influenced by structural modifications:

• Electron-withdrawing groups → ↑ antibacterial activity
• Heterocyclic hybrids → ↑ spectrum and potency
• Thiol (–SH) group → ↑ enzyme binding
• Schiff base derivatives → ↑ antifungal activity

Hybrid molecules combining triazole with other pharmacophores have shown enhanced activity and improved pharmacokinetic profile .

6. In-Silico Studies and Molecular Docking

In recent years, in-silico techniques have become indispensable tools in drug discovery, particularly in the design and evaluation of antimicrobial agents. Molecular docking and computational modeling enable the prediction of interactions between ligands and biological targets, thereby reducing time, cost, and experimental effort associated with conventional drug development. For 1,2,4-triazole derivatives, in-silico studies provide valuable insights into binding mechanisms, structure optimization, and pharmacokinetic properties.

6.1 Importance of In-Silico Studies

In-silico methods play a crucial role in rational drug design by predicting biological activity prior to synthesis. These approaches allow screening of large compound libraries, identification of lead molecules, and optimization of chemical structures. Molecular docking, quantitative structure–activity relationship (QSAR), and molecular dynamics simulations are commonly employed to evaluate antimicrobial potential.

Recent studies have demonstrated that computational analysis of 1,2,4-triazole derivatives correlates well with experimental antimicrobial activity, validating the effectiveness of these approaches in drug discovery [1].

6.2 Molecular Docking: Principle and Methodology

Molecular docking is a computational technique used to predict the preferred orientation of a ligand when bound to a target protein, forming a stable ligand–protein complex. The goal is to estimate binding affinity and identify key interactions such as hydrogen bonding, hydrophobic interactions, and electrostatic forces.

The docking process generally involves the following steps:

1. Ligand preparation (geometry optimization)
2. Protein preparation (removal of water molecules, addition of hydrogen atoms)
3. Active site identification
4. Docking simulation
5. Scoring and ranking of binding affinity

Binding energy (kcal/mol) is used as a key parameter, where lower values indicate stronger interactions and better biological activity.

6.3 Target Proteins for Antimicrobial Activity

For 1,2,4-triazole derivatives, molecular docking studies are commonly performed against key microbial targets, including:

• DNA gyrase → involved in bacterial DNA replication
• Dihydrofolate reductase (DHFR) → essential for folate metabolism
• Lanosterol 14α-demethylase → critical in fungal ergosterol synthesis
• Thymidine phosphorylase → enzyme linked to microbial growth

Docking studies have shown that triazole derivatives exhibit strong binding affinity toward these targets, supporting their antimicrobial activity [2], [3].

6.4 Molecular Docking of 1,2,4-Triazole Derivatives

Several studies have reported successful docking of 1,2,4-triazole derivatives with microbial proteins. For example, synthesized triazole compounds demonstrated strong binding interactions with bacterial and fungal proteins, showing significant antimicrobial activity comparable to standard drugs such as amoxicillin and fluconazole .

In another study, molecular docking and molecular dynamics simulations revealed that triazole derivatives form stable complexes with target enzymes, exhibiting favorable binding energies and interaction profiles, including hydrogen bonding and π–π stacking interactions .

Furthermore, hybrid triazole compounds have shown excellent docking scores against DNA gyrase and fungal enzymes, correlating well with their in-vitro antimicrobial activity .

6.5 Molecular Dynamics and Advanced Computational Studies

Molecular dynamics (MD) simulations complement docking studies by providing insights into the stability of ligand–protein complexes over time. These simulations evaluate parameters such as root mean square deviation (RMSD), flexibility, and conformational stability.

Recent studies combining docking and MD simulations have demonstrated that triazole derivatives maintain stable interactions within the active site of target proteins, reinforcing their potential as antimicrobial agents [2].

6.6 ADME and Drug-Likeness Prediction

In addition to docking, in-silico ADME (Absorption, Distribution, Metabolism, and Excretion) analysis is essential for evaluating drug-likeness. Parameters such as Lipinski’s rule of five, bioavailability, and toxicity are assessed to predict pharmacokinetic behavior.

These studies help in identifying compounds with optimal biological activity and minimal toxicity, thereby improving the success rate of drug development.

6.7 Correlation Between Docking and Biological Activity

A strong correlation has been observed between docking scores and experimental antimicrobial activity. Compounds exhibiting lower binding energies generally show better inhibitory activity (lower MIC values). This correlation validates the use of molecular docking as a predictive tool in antimicrobial research.

For example, triazole derivatives with high binding affinity toward DNA gyrase and fungal enzymes have demonstrated enhanced antimicrobial activity, confirming the reliability of in-silico predictions.

7. Pharmacokinetic and Toxicological Considerations

The successful development of 1,2,4-triazole derivatives as antimicrobial agents depends not only on their biological efficacy but also on their pharmacokinetic (ADME) and toxicological profiles. Evaluation of these parameters is essential to ensure optimal drug performance, safety, and therapeutic effectiveness. Recent advances in computational and experimental methods have facilitated early prediction of pharmacokinetic behavior and toxicity, thereby reducing the risk of late-stage drug failure.

7.1 Absorption, Distribution, Metabolism, and Excretion (ADME)

Pharmacokinetic properties of 1,2,4-triazole derivatives are largely influenced by their structural features, including lipophilicity, molecular weight, and hydrogen bonding capacity. Most triazole-based compounds exhibit favorable oral bioavailability due to their moderate polarity and ability to cross biological membranes.

• Absorption: Triazole derivatives generally show good gastrointestinal absorption, which is attributed to their compliance with Lipinski’s rule of five. Structural modifications, such as the introduction of lipophilic substituents, can further enhance membrane permeability [1].
• Distribution: These compounds demonstrate moderate to high plasma protein binding and are capable of penetrating tissues effectively. Some triazole derivatives also exhibit the ability to cross the blood–brain barrier depending on their polarity and molecular size [2].
• Metabolism: Triazole derivatives are primarily metabolized in the liver via cytochrome P450 enzymes. The presence of nitrogen atoms in the ring often contributes to metabolic stability; however, certain derivatives may inhibit CYP enzymes, leading to potential drug–drug interactions [3].
• Excretion: Elimination typically occurs through renal and biliary pathways. Structural optimization can influence the half-life and clearance rate of these compounds.

7.2 Drug-Likeness and Lipinski’s Rule

Drug-likeness evaluation is a crucial step in determining whether a compound is suitable for oral administration. Most biologically active 1,2,4-triazole derivatives obey Lipinski’s rule of five, which includes:

• Molecular weight < 500 Da
• Log P < 5
• Hydrogen bond donors ≤ 5
• Hydrogen bond acceptors ≤ 10

Compounds satisfying these criteria generally exhibit good bioavailability and permeability. Computational tools such as SwissADME are widely used to predict these parameters and guide molecular design [4].

7.3 Toxicological Considerations

Toxicity evaluation is essential to ensure the safety of triazole derivatives. Although many triazole-based drugs are clinically safe, certain derivatives may exhibit cytotoxicity or off-target effects.

• Hepatotoxicity: Some triazole derivatives may affect liver function due to interaction with cytochrome P450 enzymes.
• Cytotoxicity: Evaluation using cell line assays indicates that most substituted triazoles show low to moderate toxicity, depending on the nature of substituents.
• Mutagenicity and Carcinogenicity: In-silico toxicity prediction tools suggest that careful structural modification can minimize mutagenic risks.

Studies have shown that incorporation of appropriate functional groups can significantly reduce toxicity while maintaining antimicrobial activity [5].

7.4 In-Silico ADMET Prediction

In recent years, in-silico ADMET prediction has become an integral part of drug development. These computational approaches allow rapid screening of pharmacokinetic and toxicological properties before synthesis.

Key parameters evaluated include:

• Human intestinal absorption (HIA)
• Blood–brain barrier permeability
• Cytochrome P450 inhibition
• Acute toxicity (LD??)

Such predictions help identify lead compounds with optimal safety and efficacy profiles, thereby accelerating the drug discovery process [6].

7.5 Optimization Strategies

To improve pharmacokinetic and toxicological profiles, the following strategies are commonly employed:

• Structural modification to balance lipophilicity and polarity
• Introduction of metabolically stable groups
• Reduction of reactive functional groups
• Use of prodrug approaches

These strategies enhance drug-likeness and minimize adverse effects, making triazole derivatives more suitable for therapeutic use.

8. Challenges and Future Perspectives

Despite the significant progress in the synthesis and biological evaluation of 1,2,4-triazole derivatives as antimicrobial agents, several challenges remain that limit their successful translation into clinically useful drugs. Addressing these limitations is essential for the future development of effective and safe antimicrobial therapies.

8.1 Challenges in the Development of 1,2,4-Triazole Derivatives

8.1.1 Antimicrobial Resistance

One of the major challenges is the rapid emergence of antimicrobial resistance (AMR), which reduces the efficacy of existing drugs. Microorganisms continuously evolve mechanisms such as target modification, efflux pump activation, and enzymatic degradation, which can also affect newly developed triazole derivatives. This necessitates the continuous design of novel compounds with unique mechanisms of action [1].

8.1.2 Limitations in Synthetic Methodologies

Although numerous synthetic routes for 1,2,4-triazoles have been developed, many conventional methods still suffer from drawbacks such as:

• Harsh reaction conditions
• Long reaction times
• Low yields
• Use of toxic reagents

These limitations hinder large-scale production and industrial application. There is a need for more efficient, cost-effective, and environmentally friendly synthetic strategies [2].

8.1.3 Toxicity and Pharmacokinetic Issues

While many triazole derivatives show potent antimicrobial activity, some compounds exhibit undesirable pharmacokinetic properties or toxicity. Issues such as poor solubility, low bioavailability, and potential hepatotoxicity due to cytochrome P450 interactions remain concerns. Balancing potency with safety continues to be a critical challenge in drug design [3].

8.1.4 Limited Clinical Translation

Despite extensive research and promising in-vitro and in-silico results, only a limited number of triazole derivatives have progressed to clinical use. The gap between laboratory findings and clinical application is often due to inadequate in-vivo studies, regulatory hurdles, and high development costs [4].

8.2 Future Perspectives

8.2.1 Development of Novel Derivatives

Future research should focus on the design of novel 1,2,4-triazole derivatives with improved antimicrobial activity and reduced resistance potential. Strategies such as hybridization with other pharmacophores and incorporation of bioactive functional groups can enhance efficacy and broaden the antimicrobial spectrum [5].

8.2.2 Green and Sustainable Synthesis

The adoption of green chemistry principles is expected to play a crucial role in future synthetic approaches. Techniques such as microwave-assisted synthesis, solvent-free reactions, and the use of ionic liquids and biodegradable catalysts can improve efficiency and reduce environmental impact [2].

8.2.3 Integration of In-Silico and AI-Based Drug Design

Advancements in computational chemistry, molecular docking, and artificial intelligence (AI) are revolutionizing drug discovery. The integration of in-silico tools with machine learning algorithms can accelerate the identification of lead compounds, optimize molecular structures, and predict pharmacokinetic and toxicological properties with greater accuracy [6].

8.2.4 Target-Based Drug Design

Future efforts should emphasize target-specific drug design, focusing on validated microbial enzymes such as DNA gyrase, dihydrofolate reductase, and lanosterol demethylase. Structure-based design can improve selectivity and reduce off-target effects, leading to more effective antimicrobial agents [5].

8.2.5 Comprehensive Biological Evaluation

There is a need for more extensive in-vivo studies and clinical trials to validate the therapeutic potential of triazole derivatives. Additionally, evaluating synergistic effects with existing antibiotics may provide new strategies to combat resistant strains [4].

CONCLUSION

The present review highlights the significant progress made in the synthesis and development of 1,2,4-triazole-based compounds as potent antimicrobial agents. The versatility of the 1,2,4-triazole scaffold, attributed to its nitrogen-rich heterocyclic structure and favorable physicochemical properties, has enabled the design of a wide range of derivatives with promising antibacterial and antifungal activities. Various conventional synthetic routes, such as cyclization of acid hydrazides and thiosemicarbazides, have been successfully employed, while modern methodologies including microwave-assisted synthesis, multicomponent reactions, and green chemistry approaches have improved efficiency, yield, and sustainability

Structure–activity relationship (SAR) studies reveal that the introduction of electron-withdrawing groups, heterocyclic moieties, and thiol functionalities significantly enhances antimicrobial activity. Hybridization strategies have further contributed to the development of compounds with broad-spectrum activity and improved pharmacological profiles . In addition, in-silico studies, particularly molecular docking and ADME prediction, have emerged as valuable tools for understanding ligand–target interactions and guiding rational drug design, thereby accelerating the discovery process

Despite these advances, challenges such as antimicrobial resistance, toxicity concerns, and limitations in clinical translation remain critical barriers. Addressing these issues requires an integrated approach combining innovative synthetic strategies, computational modeling, and comprehensive biological evaluation. Future research should focus on the development of novel triazole derivatives with improved selectivity, reduced toxicity, and enhanced pharmacokinetic properties.

In conclusion, 1,2,4-triazole derivatives continue to represent a promising class of compounds in antimicrobial drug discovery. The integration of advanced synthetic methodologies with modern computational techniques is expected to play a pivotal role in the development of next-generation antimicrobial agents capable of overcoming current resistance challenges

ACKNOWLEDGMENT

The authors would like to express their sincere gratitude to their respective institution for providing the necessary facilities and academic environment to carry out this work. The authors also acknowledge the support of faculty members and colleagues for their valuable discussions and guidance during the preparation of this review.

We are thankful to the scientific community for their continuous contributions in the field of medicinal chemistry, particularly in the development of 1,2,4-triazole derivatives as antimicrobial agents. The availability of numerous research articles, databases, and computational tools has significantly facilitated the compilation and analysis of the literature presented in this review.

The authors also appreciate the developers of computational resources and online platforms that enabled in-silico studies and pharmacokinetic predictions, which contributed to a better understanding of the subject.

REFERENCES

1. C. L. Ventola, “The antibiotic resistance crisis: part 1: causes and threats,” P & T, vol. 40, no. 4, pp. 277–283, 2015.
2. World Health Organization, “Antimicrobial resistance: global report on surveillance,” 2014.
3. J. K. Gupta, R. K. Yadav, and S. Singh, “1,2,4-Triazole: a review of biological activities,” J. Chem. Pharm. Res., vol. 6, pp. 902–907, 2014.
4. A. Demirbas, N. Demirbas, S. A. Karaoglu, and A. Celik, “Synthesis and antimicrobial activities of some new 1,2,4-triazoles,” Eur. J. Med. Chem., vol. 44, no. 3, pp. 1057–1066, 2009. https://doi.org/10.1016/j.ejmech.2008.06.019
5. B. K. Banik, F. F. Becker, and R. Banik, “Microwave-assisted synthesis of heterocycles,” J. Med. Chem., vol. 46, no. 1, pp. 12–15, 2003. https://doi.org/10.1021/jm0255654
6. C. O. Kappe, “Controlled microwave heating in modern organic synthesis,” Angew. Chem. Int. Ed., vol. 43, pp. 6250–6284, 2004. https://doi.org/10.1002/anie.200400655
7. H. Bayrak et al., “Synthesis and antimicrobial activity of some new 1,2,4-triazole derivatives,” Eur. J. Med. Chem., vol. 44, no. 3, pp. 1057–1066, 2009. https://doi.org/10.1016/j.ejmech.2008.06.019
8. D. E. Clark and S. D. Pickett, “Computational methods for the prediction of drug metabolism,” Drug Discov. Today, vol. 5, no. 2, pp. 49–58, 2000. https://doi.org/10.1016/S1359-6446(99)01492-9
9. A. R. Katritzky and C. W. Rees, Comprehensive Heterocyclic Chemistry, Oxford: Pergamon Press, 1984.
10. J. Elguero, “Tautomerism of heterocycles,” Adv. Heterocycl. Chem., vol. 1, pp. 1–84, 1963. https://doi.org/10.1016/S0065-2725(08)60203-3
11. S. Rollas and S. G. Küçükgüzel, “Biological activities of hydrazone derivatives,” Molecules, vol. 12, no. 8, pp. 1910–1939, 2007. https://doi.org/10.3390/12081910
12. J. Elguero et al., The Tautomerism of Heterocycles, Academic Press, 1976.
13. N. Demirbas, A. Demirbas, and S. A. Karaoglu, “Synthesis and antimicrobial activity of some new triazoles,” Eur. J. Med. Chem., vol. 44, pp. 1057–1066, 2009. https://doi.org/10.1016/j.ejmech.2008.06.019
14. P. Lass-Flörl, “Triazole antifungal agents in invasive fungal infections,” Drugs, vol. 71, no. 18, pp. 2405–2419, 2011. https://doi.org/10.2165/11596390-000000000-00000
15. S. C. Rodrigues et al., “A review on chemistry and methods of synthesis of 1,2,4-triazole derivatives,” Chem. Rec., vol. 25, no. 1, 2025. https://doi.org/10.1002/tcr.202400190
16. X. Yang, Z. Liu, et al., “Synthesis methods of 1,2,3-/1,2,4-triazoles: A review,” Front. Chem., vol. 10, 2022. https://doi.org/10.3389/fchem.2022.891484
17. S. Swami et al., “Recent advances in microwave-assisted synthesis of triazoles,” RSC Adv., vol. 15, 2025. https://doi.org/10.1039/D4RA06886F
18. X. Zhang et al., “Microwave-assisted annulation for synthesis of 1,2,4-triazoles,” J. Org. Chem., 2025. https://doi.org/10.1021/acs.joc.4c03089
19. A. Chawla and P. Kaur, “Microwave synthesis as green chemistry approach for triazoles,” Int. Res. J. Pharm., 2024.
20. M. Strzelecka and P. ?wi?tek, “1,2,4-Triazoles as important antibacterial agents,” Pharmaceuticals, vol. 14, no. 3, p. 224, 2021. https://doi.org/10.3390/ph14030224
21. S. V. Shiraguppi et al., “A review on 1,2,4-triazoles as scaffold for various pharmacological activities,” J. Pharma Insights Res., 2025. https://doi.org/10.69613/aewrja40
22. R. Aggarwal and G. Sumran, “An insight on medicinal attributes of 1,2,4-triazoles,” Eur. J. Med. Chem., 2020. https://doi.org/10.1016/j.ejmech.2020.112652
23. G. Tian et al., “Recent advances in 1,2,3- and 1,2,4-triazole hybrids as antimicrobials and their SAR: A critical review,” Eur. J. Med. Chem., vol. 259, p. 115603, 2023. https://doi.org/10.1016/j.ejmech.2023.115603
24. T. Önkol et al., “Synthesis and antimicrobial activity of new 1,2,4-triazole derivatives,” J. Enzyme Inhib. Med. Chem., 2008. https://doi.org/10.1080/14756360701408697
25. M. Strzelecka and P. ?wi?tek, “1,2,4-Triazoles as important antibacterial agents,” Pharmaceuticals, vol. 14, no. 3, p. 224, 2021. https://doi.org/10.3390/ph14030224
26. Y. Jiang et al., “Design, synthesis, and antimicrobial evaluation of novel 1,2,4-triazole derivatives,” RSC Adv., 2025. https://doi.org/10.1039/D5RA04574F
27. F. Gao et al., “Antibacterial activity study of 1,2,4-triazole derivatives,” Eur. J. Med. Chem., 2019. https://doi.org/10.1016/j.ejmech.2019.04.043
28. H. Chavan et al., “Synthesis and evaluation of 1,2,4-triazole derivatives as antimicrobial agents,” Indian J. Chem., 2022. https://doi.org/10.56042/ijc.v61i9.66354
29. A. A. Mosleh and Z. A. Dakhel, “Synthesis and antimicrobial activity of sulfonamide–triazole derivatives,” Iraqi J. Pharm. Sci., 2024. https://doi.org/10.31351/vol33iss(4SI)pp321-335
30. M. Gao et al., “Synthesis and antifungal activity of triazole derivatives,” Eur. J. Med. Chem., 2015.
31. S. Sharma et al., “In silico molecular docking and molecular dynamics analysis of antimicrobial triazole derivatives,” Comb. Chem. High Throughput Screen., 2025. https://doi.org/10.2174/0113862073314430240730095615
32. M.-Y. Xia et al., “Synthesis, antimycobacterial evaluation, and molecular docking study of 1,2,4-triazole derivatives,” J. Enzyme Inhib. Med. Chem., vol. 38, no. 1, 2023. https://doi.org/10.1080/14756366.2023.2229070
33. M. A. M. Ali et al., “Synthesis, molecular docking study and antimicrobial evaluation of 1,2,4-triazole compounds,” Indian J. Pharm. Educ. Res., 2025. https://doi.org/10.5530/ijper.20255394
34. S. K. Verma et al., “Molecular docking studies of triazole derivatives as antimicrobial agents,” J. Mol. Struct., vol. 1223, 2021. https://doi.org/10.1016/j.molstruc.2020.129216
35. D. Ashok et al., “Microwave-assisted synthesis and docking studies of triazole derivatives,” RSC Adv., 2023. https://doi.org/10.1039/D2RA05960F
36. C. A. Lipinski, “Lead- and drug-like compounds: the rule-of-five revolution,” Drug Discov. Today Technol., vol. 1, no. 4, pp. 337–341, 2004. https://doi.org/10.1016/j.ddtec.2004.11.007
37. A. Daina, O. Michielin, and V. Zoete, “SwissADME: a free web tool to evaluate pharmacokinetics and drug-likeness,” Sci. Rep., vol. 7, p. 42717, 2017. https://doi.org/10.1038/srep42717
38. P. Lass-Flörl, “Triazole antifungal agents in invasive fungal infections,” Drugs, vol. 71, no. 18, pp. 2405–2419, 2011. https://doi.org/10.2165/11596390-000000000-00000
39. C. A. Lipinski et al., “Experimental and computational approaches to estimate solubility and permeability,” Adv. Drug Deliv. Rev., vol. 46, pp. 3–26, 2001. https://doi.org/10.1016/S0169-409X(00)00129-0
40. M. Strzelecka and P. ?wi?tek, “1,2,4-Triazoles as important antibacterial agents,” Pharmaceuticals, vol. 14, no. 3, p. 224, 2021. https://doi.org/10.3390/ph14030224
41. D. E. Clark and S. D. Pickett, “Computational methods for the prediction of drug metabolism,” Drug Discov. Today, vol. 5, no. 2, pp. 49–58, 2000. https://doi.org/10.1016/S1359-6446(99)01492-9
42. C. L. Ventola, “The antibiotic resistance crisis: part 1: causes and threats,” P & T, vol. 40, no. 4, pp. 277–283, 2015.
43. C. O. Kappe, “Controlled microwave heating in modern organic synthesis,” Angew. Chem. Int. Ed., vol. 43, pp. 6250–6284, 2004. https://doi.org/10.1002/anie.200400655
44. P. Lass-Flörl, “Triazole antifungal agents in invasive fungal infections,” Drugs, vol. 71, no. 18, pp. 2405–2419, 2011. https://doi.org/10.2165/11596390-000000000-00000
45. M. Strzelecka and P. ?wi?tek, “1,2,4-Triazoles as important antibacterial agents,” Pharmaceuticals, vol. 14, no. 3, p. 224, 2021. https://doi.org/10.3390/ph14030224
46. G. Tian et al., “Recent advances in triazole hybrids as antimicrobial agents,” Eur. J. Med. Chem., vol. 259, p. 115603, 2023. https://doi.org/10.1016/j.ejmech.2023.115603
47. D. E. Clark and S. D. Pickett, “Computational methods for drug discovery,” Drug Discov. Today, vol. 5, no. 2, pp. 49–58, 2000. https://doi.org/10.1016/S1359-6446(99)01492-9